The Workers Compensation Research Institute posted lots of excellent research and topped it off with a webinar. I’ll be diving into these later, but for those champing at the bit, here’s a brief summary.
The research included:
PhRMA appears to be holding off efforts to enable the government to negotiate drug prices for Medicare and Medicaid members. The $22.4 million it spent on lobbying is a pittance compared to the profits the industry is generating.
Three Democrats in states with lots of pharma companies appear to be holding things up, soaking up big bucks in campaign donations in the process.
And then there’s COVID.
New research indicates “natural immunity from a COVID-19 infection fades quickly, leaving individuals susceptible to reinfection.” Published in The Lancet, the study found that a previous COVID infection does not provide much protection against re-infection.
Research published by the Kaiser Family Foundation indicates that 90,000 of our family members, dear friends, colleagues and coworkers didn’t have to die of COVID. That’s the estimated number of additional deaths due to failures to be vaccinated.
Oh, and the number of vaccinated people who died of COVID was tiny by comparison, so don’t believe that B.S. about Colin Powell.
Health systems are ramping up terminations of workers who refuse to get vaccinated, but the number of those fired remains pretty low.
What does this mean for you?
WCRI does great work.
Get vaccinated and wear a mask.
Joseph Paduda is co-owner of CompPharma, a consulting firm focused on improving pharmacy programs in workers’ compensation. This column is republished with his permission from his Managed Care Matters blog.
May 5-8, 2024
Amplify Your Impact There’s no limit to what you can achieve when you join the global risk managem …
May 13-15, 2024
Join us May 13–15, 2024, for NCCI's Annual Insights Symposium (AIS) 2024, the industry’s premier e …
May 13-14, 2024
The Board of Managers is excited to announce that the CSIA 2024 Annual Meeting and Educational Con …
No Comments
Log in to post a comment